0001209191-20-062314.txt : 20201208
0001209191-20-062314.hdr.sgml : 20201208
20201208170030
ACCESSION NUMBER: 0001209191-20-062314
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201205
FILED AS OF DATE: 20201208
DATE AS OF CHANGE: 20201208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DesJardin Michael A.
CENTRAL INDEX KEY: 0001512985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 201375994
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS, INC.
STREET 2: 3180 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-05
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001512985
DesJardin Michael A.
C/O HORIZON THERAPEUTICS PLC,
CONNAUGHT HOUSE 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
0
1
0
0
EVP, Technical Operations
Ordinary Shares
2020-12-05
4
M
0
5861
A
72207
D
Ordinary Shares
2020-12-05
4
F
0
2906
71.72
D
69301
D
Restricted Stock Units
2020-12-05
4
M
0
5861
0.00
D
Ordinary Shares
5861
0
D
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
Includes 1,987 ordinary shares of the Issuer which were acquired pursuant to an employee stock purchase program, including 1,005 ordinary shares acquired on June 1, 2020 and 982 ordinary shares acquired on December 1, 2020.
Reflects the net settlement of ordinary shares of the Issuer in connection with the vesting of restricted stock units.
On December 15, 2016, the reporting person was granted 23,442 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the vesting commencement date of December 5, 2016.
/s/ Miles W. McHugh, Attorney-in-Fact
2020-12-08